Glenmede Trust Company Na Has Upped Citigroup (C) Position; Bio-techne (TECH) Sellers Increased By 9.58% Their Shorts

April 25, 2018 - By Kurt Siggers

Citigroup Inc. (NYSE:C) Logo

Bio-techne Corp (NASDAQ:TECH) had an increase of 9.58% in short interest. TECH’s SI was 975,500 shares in April as released by FINRA. Its up 9.58% from 890,200 shares previously. With 175,600 avg volume, 6 days are for Bio-techne Corp (NASDAQ:TECH)’s short sellers to cover TECH’s short positions. The SI to Bio-techne Corp’s float is 2.61%. The stock decreased 0.60% or $0.92 during the last trading session, reaching $151.56. About 156,181 shares traded. Bio-Techne Corporation (NASDAQ:TECH) has risen 45.31% since April 25, 2017 and is uptrending. It has outperformed by 33.76% the S&P500.

Glenmede Trust Company Na increased Citigroup Inc (C) stake by 12.39% reported in 2017Q4 SEC filing. Glenmede Trust Company Na acquired 10,597 shares as Citigroup Inc (C)’s stock declined 9.55%. The Glenmede Trust Company Na holds 96,142 shares with $7.15 million value, up from 85,545 last quarter. Citigroup Inc now has $176.86 billion valuation. The stock increased 0.35% or $0.24 during the last trading session, reaching $69.36. About 15.94M shares traded. Citigroup Inc. (NYSE:C) has risen 17.06% since April 25, 2017 and is uptrending. It has outperformed by 5.51% the S&P500.

Since February 13, 2018, it had 0 insider purchases, and 1 sale for $680,303 activity. Dinarello Charles A sold 5,000 shares worth $680,303.

Among 9 analysts covering BIO-TECHNE Corp (NASDAQ:TECH), 5 have Buy rating, 0 Sell and 4 Hold. Therefore 56% are positive. BIO-TECHNE Corp had 23 analyst reports since August 18, 2015 according to SRatingsIntel. The firm earned “Equal-Weight” rating on Thursday, October 29 by Stephens. The firm has “Sell” rating by Zacks given on Tuesday, September 1. As per Monday, March 27, the company rating was downgraded by Janney Capital. The stock of Bio-Techne Corporation (NASDAQ:TECH) earned “Buy” rating by Citigroup on Thursday, February 9. As per Monday, October 23, the company rating was maintained by Robert W. Baird. The rating was upgraded by Zacks to “Sell” on Tuesday, August 18. Wells Fargo initiated it with “Hold” rating and $11000 target in Thursday, July 13 report. Robert W. Baird maintained Bio-Techne Corporation (NASDAQ:TECH) rating on Tuesday, October 31. Robert W. Baird has “Buy” rating and $140.0 target. The stock has “Outperform” rating by Leerink Swann on Thursday, November 10. The firm has “Buy” rating by Robert W. Baird given on Tuesday, February 6.

Investors sentiment decreased to 0.98 in 2017 Q4. Its down 0.23, from 1.21 in 2017Q3. It is negative, as 27 investors sold Bio-Techne Corporation shares while 88 reduced holdings. 34 funds opened positions while 79 raised stakes. 35.53 million shares or 1.06% less from 35.91 million shares in 2017Q3 were reported. The Massachusetts-based Amundi Pioneer Asset Mngmt has invested 0.02% in Bio-Techne Corporation (NASDAQ:TECH). Comerica Retail Bank invested in 32,935 shares or 0.03% of the stock. Jane Street Gp Limited Liability Com holds 0% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH) for 3,016 shares. Fort Washington Inv Advisors Incorporated Oh has invested 0.15% in Bio-Techne Corporation (NASDAQ:TECH). Dimensional Fund Advisors Limited Partnership holds 0.01% in Bio-Techne Corporation (NASDAQ:TECH) or 203,188 shares. Palisade Asset Management Ltd holds 0.33% or 15,933 shares. 1.34 million were reported by Select Equity Grp Ltd Partnership. Schwab Charles Investment Mgmt holds 0.02% or 206,510 shares in its portfolio. Oppenheimer Asset invested 0.04% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH). Osterweis Cap Mgmt invested in 42,870 shares or 0.39% of the stock. Leavell Investment invested in 17,951 shares. Hudson Bay Cap Ltd Partnership reported 0.22% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH). Thrivent For Lutherans stated it has 0% in Bio-Techne Corporation (NASDAQ:TECH). Teacher Retirement Of Texas stated it has 12,753 shares or 0.01% of all its holdings. Huntington Comml Bank has 0% invested in Bio-Techne Corporation (NASDAQ:TECH).

Bio-Techne Corporation, together with its subsidiaries, develops, makes, and sells biotechnology reagents, instruments, and clinical diagnostic controls worldwide. The company has market cap of $5.68 billion. It operates through three divisions: Biotechnology, Protein Platforms, and Diagnostics. It has a 49.84 P/E ratio. The Biotechnology segment offers native and recombinant proteins, monoclonal and polyclonal antibodies, immunoassays, biologically active chemical compounds, and in situ genomic hybridization assays for the research and clinical diagnostics markets.

Among 40 analysts covering Citigroup Inc. (NYSE:C), 23 have Buy rating, 2 Sell and 15 Hold. Therefore 58% are positive. Citigroup Inc. had 124 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Citigroup Inc. (NYSE:C) earned “Sell” rating by Societe Generale on Monday, October 16. Atlantic Securities upgraded the shares of C in report on Wednesday, December 21 to “Overweight” rating. The company was downgraded on Tuesday, January 16 by Keefe Bruyette & Woods. On Wednesday, August 26 the stock rating was downgraded by JP Morgan to “Overweight”. Keefe Bruyette & Woods maintained Citigroup Inc. (NYSE:C) on Tuesday, January 19 with “Outperform” rating. The firm earned “Overweight” rating on Tuesday, January 3 by Barclays Capital. The company was maintained on Monday, October 2 by Wells Fargo. The stock of Citigroup Inc. (NYSE:C) has “Buy” rating given on Wednesday, September 7 by Nomura. The rating was maintained by Nomura with “Buy” on Monday, July 17. The stock of Citigroup Inc. (NYSE:C) earned “Hold” rating by Zacks on Tuesday, August 25.

Since February 27, 2018, it had 0 buys, and 6 selling transactions for $4.97 million activity. 6,466 shares valued at $500,666 were sold by Forese James A. on Tuesday, February 27. Fraser Jane Nind also sold $2.51 million worth of Citigroup Inc. (NYSE:C) shares. The insider MURRAY JOSEPH MICHAEL sold 3,400 shares worth $263,126. Shares for $611,804 were sold by Hu W. Bradford on Tuesday, February 27. Callahan Don sold $536,410 worth of Citigroup Inc. (NYSE:C) on Wednesday, February 28. Another trade for 7,000 shares valued at $542,920 was made by Gerspach John C on Tuesday, February 27.

Glenmede Trust Company Na decreased Agco Corp (NYSE:AGCO) stake by 5,826 shares to 57,047 valued at $4.07M in 2017Q4. It also reduced Abb Ltd (NYSE:ABB) stake by 287,608 shares and now owns 35,620 shares. Stanley Black & Decker Inc (NYSE:SWK) was reduced too.

Citigroup Inc. (NYSE:C) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts